Abiopharma

🔍 Quinn William P. (Executive)

Company: Bolt Biotherapeutics, Inc. (BOLT)

Report Date: 2026-01-28

Detailed Transactions and Holdings:

• Acquired 125 shares of Common Stock at $4.607 per share (Direct)
  Date: 2025-12-05 | Code: P | equity_swap_involved: false | shares_owned_after: 2,313.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 20,000 shares of Employee Stock Option (Right to Buy) at $6.71 per share (Derivative)
  Date: 2026-01-28 | Code: A | Expires: 2036-01-27 | equity_swap_involved: false | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
• F2: For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026.